Puissance Capital Management LP
10% owner at Bellerophon Therapeutics, Inc.; 10% owner at Tracon Pharmaceuticals, Inc.
- Sold, on record
- $6.5M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Jun 7, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Bellerophon Therapeutics, Inc.10% owner
- Tracon Pharmaceuticals, Inc.10% owner
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- Bellerophon Therapeutics, Inc.694,421 shares
- Tracon Pharmaceuticals, Inc.384,130 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Tracon Pharmaceuticals, Inc.UnusualDec 9, 2019 2019
Sold 384,130 shares at $2.93 ($1.1M)
Puissance Capital Management LP, 10% owner
Sold 83.5% of holdings ($1.4M position)76,048 shares leftFirst sale on recordFiling
- 2 Form 4 sale Bellerophon Therapeutics, Inc.UnusualMay 18, 2023 +1256 days
Sold 560,000 shares at $9.46 ($5.3M)
Puissance Capital Management LP, 10% owner
No 10b5-1 planSold 31.6% of holdings ($16.8M position)1.2M shares leftFirst sale on recordFiling
- 3 Form 4 sale Bellerophon Therapeutics, Inc.No planJun 7, 2023 +20 days
Sold 134,421 shares at $0.83 ($112k)
Puissance Capital Management LP, 10% owner
No 10b5-1 planSold 11.1% of holdings ($1M position)1.1M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2023 | Jun 7, 2023 | Bellerophon Therapeutics, Inc. | 10% owner | Form 4 sale | 134,421 | $112k | 11.1% | No plan | SEC |
| May 18, 2023 | May 19, 2023 | Bellerophon Therapeutics, Inc. | 10% owner | Form 4 sale | 560,000 | $5.3M | 31.6% | Unusual | SEC |
| Dec 9, 2019 | Dec 11, 2019 | Tracon Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 384,130 | $1.1M | 83.5% | Unusual | SEC |